The study uses two medications: ropivacaine hydrochloride (a local anesthetic that numbs specific areas) and sodium chloride solution (salt water). Some patients will receive the pain-blocking medication, while others will receive placebo. The purpose is to determine if this nerve-blocking technique can improve recovery after heart surgery.

During the study, patients will receive injections on both sides of their chest after surgery. Their recovery will be monitored through various assessments, including pain levels and overall well-being. The research team will evaluate how well patients recover in the first few days after surgery and follow up with them for one month to assess their healing progress.

The purpose of the study is to evaluate how the body processes the medication and to monitor its safety. Researchers will observe how the drug is absorbed into the bloodstream, how it moves throughout the body, and how it is eventually eliminated. Additionally, the study will track how the body reacts to the treatment to ensure it is safe for use in this age group.

The purpose of the study is to find out whether a lower dose or a medium dose of dexamethasone given through an intravenous injection, which means directly into a vein, is more effective at reducing the occurrence of rebound pain after foot surgery. Patients in this study will undergo open orthopedic foot surgery, which is a type of surgery where the surgeon makes an incision to access and repair structures in the foot. The surgery will be performed on an outpatient basis, meaning patients can go home the same day rather than staying overnight in the hospital. All patients will receive the nerve block for pain control during surgery, and they will also receive one of the two doses of dexamethasone to help prevent severe pain from returning suddenly when the nerve block wears off.

During the study, patients will have their pain levels checked at specific times after surgery through telephone calls at 24 hours, 48 hours, and 72 hours following the procedure. Pain will be measured using a scale where zero means no pain and ten means the worst pain imaginable. The study will track when patients first feel pain at the surgical site after the nerve block stops working, and will also monitor for any unwanted effects related to the medication, such as high blood sugar levels measured before patients leave the hospital, or problems with wound healing that might occur up to one month after surgery.

The purpose of the study is to see if using 20 milliliters of Bupivacaine can reduce the need for pain medications, specifically opioids, within the first 24 hours after surgery. Participants will be randomly assigned to receive either 10 milliliters or 20 milliliters of the anesthetic. The study will monitor how much pain medication is needed, the level of pain experienced, and how well patients recover after their knee surgery.

Throughout the study, researchers will collect information on various aspects of recovery, such as pain levels at rest and during movement, the ability to walk with crutches, and overall recovery quality. The goal is to determine the most effective amount of Bupivacaine for managing pain and improving recovery after knee replacement surgery.

Participants in the study will be randomly assigned to receive either etoricoxib, celecoxib, or a placebo. The study is designed to be double-masked, meaning neither the participants nor the researchers will know which treatment each participant is receiving, to ensure unbiased results. The trial will observe the effects of these medications over a short period, focusing on their ability to lessen pain and discomfort after the surgery.

The study aims to determine if one of these medications is more effective than the other in reducing postoperative pain. It is anticipated that those receiving etoricoxib may experience a greater reduction in pain compared to those receiving a placebo, based on the known properties of the drug. This research could help improve pain management strategies for patients undergoing wisdom tooth removal in the future.

The purpose of the study is to assess how well the Fentanyl Nasal Spray works in reducing pain after surgery. Participants will use the nasal spray after undergoing orthopedic surgery, which involves procedures like knee joint replacement or fixing broken bones. The study will last up to 120 hours, during which the participants’ pain levels will be monitored and compared to those using the placebo spray and morphine injections.

Throughout the study, participants will be asked to rate their pain at various times to help researchers understand the effectiveness of the treatments. The study aims to provide insights into whether the Fentanyl Nasal Spray can be a reliable option for managing pain after surgery, potentially offering a more convenient alternative to traditional methods like morphine injections.

The purpose of the study is to compare this new approach to the traditional opioid-based treatment in terms of pain relief, recovery after surgery, and overall health outcomes. Participants will receive either the new treatment or the conventional treatment, which may include a placebo. The study will monitor various aspects of recovery, including pain levels, the amount of opioids used, and the patient’s ability to recover and return to normal activities. The study will also look at how this approach affects the patient’s confidence in managing unexpected events and their quality of life over time.

Throughout the study, participants will be observed at different intervals, such as immediately after surgery, during their hospital stay, and at several points after discharge, including 3, 6, 12, and 24 months later. The goal is to see if the opioid-sparing approach can provide effective pain management and improve recovery without the side effects associated with high opioid use. This research aims to offer better pain management strategies for patients undergoing obesity surgery, potentially leading to improved health outcomes and quality of life.

Participants in the study will receive either the pain medication or a placebo. The study will monitor pain levels using a simple scale from 0 to 10, where 0 means no pain and 10 means the worst pain imaginable. This will be checked 8 hours after the surgery and at various times over the next two days. The study will also look at how much additional pain medication is needed during the first 48 hours after surgery and will track any side effects or complications that might occur, such as nausea or dizziness.

The study aims to provide valuable information on how to manage pain effectively after hip replacement surgery, potentially leading to better recovery experiences for patients. Participants will be asked about their pain experiences and overall recovery at different points in time, including the first and second days after surgery, as well as one week and one month later. This information will help assess the overall quality of recovery and the effectiveness of the pain management strategies being tested.

During the study, participants will receive either oral or intravenous pain medications. The medications will be administered before and after the surgery. Sodium chloride solution will be used for intravenous infusions. Pain levels will be measured using a numerical scale that helps patients rate their pain intensity. Additional aspects being studied include the need for extra pain medication, time until discharge from the hospital, and any side effects such as nausea or vomiting.

The study is designed as a double-blinded trial, which means neither the patients nor the healthcare providers directly involved in patient care will know which type of pain medication (oral or intravenous) is being given. This approach helps ensure that the results are not influenced by expectations about which treatment might work better. The study will also look at how well patients recover and evaluate the cost-effectiveness of both treatment approaches.